RxDoctor Payments Data

Holly Powderly, NP

Nurse Practitioner · Chelmsford, MANPI 1619209053

Payments from drug & device makers

$1,000in general payments, 2019–2025

Across 46 payments — averaging $21.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$156
  • AstraZeneca$128
  • Bayer$103
  • GSK$84
  • Lundbeck LLC$76
  • Merck$64
  • plus $389 from 10 others

What the payments were for

  • Food & beverage$1,000100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,000 in reported general payments places this provider in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.

See all nurse practitioner providers in Massachusetts

Medicare billing

Part B allowed, 2024
$23,187
Medicare patients
114
Services billed
281

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$45,846
TrulicityDulaglutide13$15,355
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$10,303
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$3,237
Albuterol Sulfate HfaAlbuterol Sulfate46$1,742
Atorvastatin Calcium72$1,392
Levothyroxine Sodium99$1,121
ValacyclovirValacyclovir Hcl21$1,085
Losartan Potassium97$944
Rosuvastatin Calcium53$894
Omeprazole49$871
Lisinopril78$851
Amlodipine Besylate97$777
Wixela InhubFluticasone Propion/Salmeterol15$629
Escitalopram Oxalate51$531

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$156$45,84642 claims
Lilly USA, LLCTrulicity$58$15,35513 claims
GSKTrelegy Ellipta$84$10,30317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.

Other nurse practitioner in Chelmsford

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →